Snap On Incorporated vs Tilray Brands Inc — how do they compare? Snap On Incorporated trades at $359.98 (market cap $18.56B), while Tilray Brands Inc trades at $3.47 (market cap $530.54M). The key difference: Snap On Incorporated is far larger — about 35× Tilray Brands Inc's market cap, and Snap On Incorporated pays a 2.72% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Snap On Incorporated for 36 Days and Tilray Brands Inc for 31 Days on average.
| SNA | TLRY | |
|---|---|---|
Market Cap | $18.56B | $530.54M |
Volume | 401,326 | 9,099,075 |
Sector | Industrials | Health |
52-Week High | $419.31 | $21.00 |
52-Week Low | $327.33 | $3.57 |
Typical Hold Time | 36 Days | 31 Days |
Enterprise Value | $18.20B | $684.46M |
Dividend Yield | 2.72% | — |
Signals from Pluang's Aura AI — not financial advice
Snap-On Incorporated (SNA) trades at $359.89, down 2.37% on the day, with technical indicators showing bearish momentum despite strong fundamentals. The company maintains robust profitability with 19.6% net margins and 17.58% ROE, supported by consistent earnings beats in recent quarters. Analyst consensus remains bullish with a $449 price target, representing 25% upside potential from current levels.
SNA offers attractive fundamentals with expanding gross margins and solid cash flow generation, though technical weakness and premium valuation present near-term headwinds. The stock's investment case hinges on continued execution of RCI initiatives and diagnostic segment growth, balanced against valuation concerns and mixed technical signals.
TLRY trades at $3.465, down 6.73% on the day and near 52-week lows, reflecting persistent bearish sentiment. The stock shows weak technical momentum with oversold RSI readings but faces fundamental challenges including consecutive quarterly earnings misses, negative profit margins, and declining revenue growth. Recent news highlights the company's struggles with profitability despite record annual revenue, with shares down over 50% year-to-date as investors question the cannabis company's path to sustainable growth.
TLRY presents a high-risk opportunity with significant downside protection from its low P/B ratio of 0.33, but requires substantial operational improvement to justify investment. The bullish case hinges on potential marijuana reform catalysts and BrewDog integration progress, while risks include ongoing losses, competitive pressures, and execution challenges in a volatile regulatory environment.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →